Catalyst Wire Dossier Catalyst Wire Dossier

HAT1 topical products

· Haus Bioceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HAT1 topical products, covering 2018-11-06 to 2018-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests [Phase 4]

See pricing